US2009104619A1PendingUtilityA1
Human G-Protein Coupled Receptors
Est. expiryMay 7, 2017(expired)· nominal 20-yr term from priority
C07K 14/705
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Two human G-Protein coupled receptor polypeptides and DNA (RNA) encoding each of such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the nucleic acid sequence of each of the G-protein coupled receptors.
Claims
exact text as granted — not AI-modified1 . An isolated polynucleotide comprising a polynucleotide having at least 95% identity to a member selected from the group consisting of:
(a) a polynucleotide encoding a polypeptide comprising amino acids 2 to 342 of SEQ ID NO:2; (b) a polynucleotide encoding a polypeptide comprising amino acids 1 to 260 of SEQ ID NO:4; (c) a polynucleotide encoding the same polypeptide encoded by the human cDNA in ATCC™ Deposit No. 209003; (d) a polynucleotide encoding the same polypeptide encoded by the human cDNA in ATCC™ Deposit No. 209004; and (e) the complement of (a), (b), (c), or (d).
2 . The isolated polynucleotide of claim 1 wherein said member is (a).
3 . The isolated polynucleotide of claim 1 wherein said member is (b).
4 . The isolated polynucleotide of claim 1 wherein said member is (c).
5 . The isolated polynucleotide of claim 1 wherein said member is (d).
6 . The isolated polynucleotide of claim 1 comprising a polynucleotide, which includes nucleotides 226-1251 of SEQ ID NO:1.
7 . The isolated polynucleotide of claim 1 comprising a polynucleotide, which includes nucleotides 2 to 827 of SEQ ID NO:3.
8 . A method of making a recombinant vector comprising inserting the isolated polynucleotide of claim 1 into a vector, wherein said polynucleotide is DNA.
9 . A recombinant vector comprising the polynucleotide of claim 1 , wherein said polynucleotide is DNA.
10 . A recombinant host cell, comprising the recombinant vector of claim 9 .
11 . A method of producing a host cell, comprising transducing, transforming or transfecting a host cell with the vector of claim 9 .
12 . A method for producing a polypeptide, comprising:
(a) culturing the recombinant host cell of claim 10 under conditions suitable to produce a polypeptide encoded by the polynucleotide; and (b) recovering the polypeptide from the cell culture.
13 . An isolated polypeptide comprising a mature polypeptide having an amino acid sequence encoded by a polynucleotide which is at least 95% identical to a member selected from the group consisting of:
(a) a polynucleotide encoding a polypeptide comprising amino acids 2 to 342 of SEQ ID NO:2; (b) a polynucleotide encoding a polypeptide comprising amino acids 1 to 260 of SEQ ID NO:4; and (c) the complement of (a) or (b).
14 . An antibody against the polypeptide of claim 13 .
15 . An antagonist against the polypeptide of claim 13 .
16 . An agonist against the polypeptide of claim 13 .
17 . A process for diagnosing a disease condition or a susceptibility to a disease condition in a subject related to the under-expression of the polypeptide of claim 13 comprising determining a mutation in a nucleic acid sequence encoding said polypeptide.Join the waitlist — get patent alerts
Track US2009104619A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.